Skip to main content

Year: 2025

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 11 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the transition ignited by the FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies. The Roadmap marks a pivotal moment in drug development. Companies that act now can future-proof their portfolios, gaining competitive advantage through faster timelines, lower costs, and stronger predictive evidence. Globally, there are thousands of monoclonal antibodies and antibody-drug conjugates (ADCs) currently in the preclinical...

Continue reading

Ocean Power Technologies Secures Order for Fully Integrated WAM-V for an International Government Customer

Assembly to begin immediately MONROE TOWNSHIP, N.J., April 14, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has secured a contract from a new international government customer for a fully integrated WAM-V for near term delivery. This contract further increases the value delivered from the Company’s previously announced expansion into certain regions, working with end customers and resellers. The vehicle will be assembled immediately and shipped to the customer. Training and services will be provided in-country. Philipp Stratmann, CEO and President of OPT, expressed his enthusiasm about this contract, stating, “Securing this contract is testament to demand...

Continue reading

Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2025 Earnings Release and Conference Call

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2025 financial results on Friday, April 25, 2025 at 10:00 a.m. Eastern Time. The Company’s first quarter 2025 financial results will be released after the market closes on Thursday, April 24, 2025. During the conference call, Company officers will review first quarter 2025 performance, discuss recent events and conduct a question-and-answer period. To register for the call, please use the following link: https://register-conf.media-server.com/register/BI9d454c5338474977930d8dafd9ec06d9 After you register, you will receive a dial-in number and unique pin. The Company will also post a link in the Stockholders’ section on ARI’s...

Continue reading

Healthy Choice Wellness Corp. Announces Same-Store Sales Growth as Part of its Record First Quarter 2025 Sales and Gross Profit Performance

HOLLYWOOD, FL, April 14, 2025 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company operating 19 natural and organic grocery stores across six states, today announced record first-quarter 2025 sales and reports positive same-store sales growth for the three months ended March 31, 2025. The Company reported strong financial performance for the first quarter of 2025, driven by impressive same-store sales growth. Key First Quarter 2025 Highlights:Same Store Sales: Increased 3%Overall Sales: Increased to $20.3 million; up $4.4 millionGross Profit: Increased to $7.9 million; up $1.8 million compared to the same period last yearJeffrey Holman, Chief Executive Officer, commented on the Company’s strong first-quarter performance, stating, “We are particularly pleased...

Continue reading

AITX’s RAD Builds Upon Urban Safety Momentum with Key Deployments in Major Cities

Cities Turn to RAD for Smarter, AI-Powered Public Safety Solutions Detroit, Michigan, April 14, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions for enterprise clients, along with its subsidiary Robotic Assistance Devices (RAD), today announced recent successes in St. Louis, Missouri, where the Downtown St. Louis Community Improvement District (CID) has embraced RAD’s solutions as part of its public safety initiatives. The CID has deployed multiple ROSA™ security devices, showcased RAD’s ROAMEO™ and RADDOG™ LE2 during the NCAA Frozen Four Championship, and is actively developing a citywide program that would introduce hundreds of RADCam™ units across St. Louis. From April 10 to 12,...

Continue reading

Can-Fite Reports 2024 Financial Results and Clinical Update

Cancer-Free Survival of 8 Years in Liver Cancer Patient Treated with Namodenoson in Prior Phase II Study RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced financial results and clinical updates for the year ended December 31, 2024. Clinical & Development Milestones Achieved Namodenoson Drug Candidate: Liver Cancer – A patient, who initially had an overall survival time of 8 years, currently treated with Namodenoson in a compassionate use program in the former Can-Fite Phase II study has evidenced a complete cure manifested by the disappearance of all metastases, normal liver function and good quality of life. In...

Continue reading

Safe & Green Holdings Corp. Announces Pricing of Approximately $8.0 Million Private Placement

MIAMI, April 14, 2025 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced the pricing of a Private Placement with gross proceeds to the Company expected to be approximately $8.0 million. The offering consists of 20,408,160 Common Units (or Pre-Funded Units), each consisting of (i) one (1) share of Common Stock or one (1) Pre-Funded Warrant, (ii) one (1) Series A Registered Common Warrant to purchase one (1) share of Common Stock per warrant at an exercise price of $0.784 (the “Series A Warrants”) and (iii) one (1) Series B Registered Common Warrant to purchase one (1) share of Common Stock per warrant at an exercise price of $0.98 (the “Series B Warrants” and...

Continue reading

Full House Resorts Announces First Quarter Earnings Release Date

LAS VEGAS, April 14, 2025 (GLOBE NEWSWIRE) — Full House Resorts (NASDAQ: FLL) announced today that it will report its first quarter 2025 financial results on Thursday, May 8, 2025, followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT). Investors can access the live audio webcast from the Company’s website at www.fullhouseresorts.com under the investor relations section. The conference call can also be accessed by dialing (646) 307-1865. A replay of the conference call will be available shortly after the conclusion of the call through May 22, 2025. To access the replay, please visit www.fullhouseresorts.com. Investors can also access the replay by dialing (412) 317-6671 and using the passcode 1125724. Forward-looking StatementsThis press release may contain statements by Full House Resorts, Inc. that are “forward-looking...

Continue reading

JDE Peet’s share buyback periodic update April 14, 2025

PRESS RELEASE Amsterdam, April 14, 2025 JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee and tea company, today announced that it has repurchased 38,272 shares in the period from April 7, 2025 up to and including April 11, 2025. The shares were repurchased at an average price of EUR 19.73 per share for a total consideration of EUR 0.8 million. These repurchases were made as part of the EUR 250 million share buyback programme announced on March 3, 2025. The total number of shares repurchased under this programme to date is 3,481,614 ordinary shares for a total consideration of EUR 64.5 million. More details on the progress of the buyback programme are available here. This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(3) of the EU Regulation 2016/1052 that contains...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.